MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
2.02
0.06 (3.06%)
At close: May 09, 2025, 3:59 PM
2.00
-0.74%
After-hours: May 09, 2025, 07:50 PM EDT
3.06% (1D)
| Bid | 1.96 |
| Market Cap | 59.62M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -23.25M |
| EPS (ttm) | -1.05 |
| PE Ratio (ttm) | -1.92 |
| Forward PE | -2.92 |
| Analyst | n/a |
| Ask | 2.19 |
| Volume | 114,857 |
| Avg. Volume (20D) | 193,332 |
| Open | 2.02 |
| Previous Close | 1.96 |
| Day's Range | 1.98 - 2.05 |
| 52-Week Range | 1.40 - 5.99 |
| Beta | 0.24 |
About MAIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAIA
Website n/a
2 months ago
-1.07%
MAIA Biotechnology shares are trading lower after ...
Unlock content with
Pro Subscription
3 months ago
+5.82%
MAIA Biotechnology shares are trading higher after the company announced updated data from its THIO-101 Phase 2 clinical trial evaluating THIO.
1 month ago · businesswire.com
MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to ShareholdersCHICAGO--(BUSINESS WIRE)--MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders.
